Neuberger Berman Group’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Neuberger Berman Group’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$959	Hold	31,552	–	–	﹤0.01%	2340
2026 Q1	$641	Hold	31,552	–	–	﹤0.01%	2161
2025 Q4	$820	Hold	31,552	–	–	﹤0.01%	2110
2025 Q3	$1.11K	Hold	31,552	–	–	﹤0.01%	2029
2025 Q2	$1.29K	Hold	31,552	–	–	﹤0.01%	2048
2025 Q1	$2.41K	Hold	31,552	–	–	﹤0.01%	1971
2024 Q4	$1.07K	Hold	31,552	–	–	﹤0.01%	1925
2024 Q3	$1K	Buy	+31,552	New	+$1.83K	﹤0.01%	1924

Other funds holding SLXNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Neuberger Berman Group's SLXNW Position: Q2 2026 in Review

Neuberger Berman Group held its Silexion Therapeutics Warrant (SLXNW) position steady in Q2 2026 at 31,552 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Neuberger Berman Group first reported a position in SLXNW in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.41K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q2 2026.

Neuberger Berman Group held 31,552 shares of Silexion Therapeutics Warrant worth $959 as of Q2 2026.
Neuberger Berman Group left its Silexion Therapeutics Warrant share count unchanged in Q2 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2340 holding.
Neuberger Berman Group first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 8 quarters since.
Neuberger Berman Group's Silexion Therapeutics Warrant position peaked at $2.41K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.